Found: 6
Select item for more details and to access through your institution.
Management of Immune Checkpoint Inhibitor Toxicities.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 9139, doi. 10.2147/CMAR.S218756
- By:
- Publication type:
- Article
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 12, p. 1597, doi. 10.1080/0284186X.2021.1978540
- By:
- Publication type:
- Article
Prognostic factors for cancer patient admitted to a medical intensive care unit.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 4, p. 458, doi. 10.1080/0284186X.2019.1711171
- By:
- Publication type:
- Article
Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients.
- Published in:
- Journal of Negative Results in Biomedicine, 2015, v. 14, p. 1, doi. 10.1186/s12952-015-0037-5
- By:
- Publication type:
- Article
Optimal management of renal cell carcinoma in the elderly: a review.
- Published in:
- Clinical Interventions in Aging, 2013, v. 8, p. 433, doi. 10.2147/CIA.S30765
- By:
- Publication type:
- Article